Page results
-
After delivering more than 80,000 vaccines, the vaccination centre at The Francis Crick Institute closes its doors today (13 August 2021) with the last vaccination taking place at 7pm.
-
After almost six months and more than 120,000 vaccinations the Islington Business Design Centre closes as a vaccination centre today (20 August 2021).
-
The Bidborough House NHS Vaccination Centre has now closed.
-
UCLH is the first NHS centre in the UK to offer patients suffering from obstructive sleep apnœa (OSA) a choice of nerve stimulation devices to manage their condition.
-
Mr Patrick Grover is a neurosurgeon with a particular expertise in the management of tumours of the skull base such as vestibular schwannomas and meningiomas, as well as Cerebral Aneurysms, AVMs and cavernomas.
-
Mr Pat O'Brien has been a consultant at UCLH since 1999 and specialises in caring for women with medical problems in pregnancy and complicated births. His research interests are in the same areas.
-
Mr Laurence Watkins is a consultant neurosurgeon with sub-speciality interests in hydrocephalus, neurovascular surgery, intracranial pressure, chronic headache and neuro-endoscopy
-
Mr Jonathan Hyam is a consultant neurosurgeon who has an interest in headache, facial pain, movement disorders, and spinal pain.
-
This page has been written for patients having proton beam therapy (PBT) at University College Hospital (UCH).
-
Patient Partners are patients, carers, families and people with lived experience of a specific issue or service. UCLH is committed to involving patients, carers, and members of the public in planning, developing, delivering, and monitoring the services we provide. Involving patients and the public in decision-making is crucial to ensuring that those services are what patients want and need.
File results
-
FOI/2022/0545 - Criteria used in determining acceptance of GP referrals for osteoporosis treatment, and for priorisation of osteoporosis appointments
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis
-
FOI/2022/0573 - Use of WhatsApp by or within the Trust